Strong immune resilience between 40–70 cuts early death risk by 69%, preserves brain health, and boosts vaccine responses.

Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at ...

A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.

Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...

A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows. Experiments in mice infected ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

Boost immunity with diet, sleep, and stress management. Learn how to fortify your body’s defenses against infections and ...

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

New research suggests that lingering cell wall fragments from the Lyme disease bacterium, Borrelia burgdorferi, may be responsible for persistent symptoms long after antibiotic treatment.

Scientists believe they know what causes the treated infection to mimic chronic illness: the body may be responding to remnants of the bacteria that causes Lyme that tend to pool in the liver and ...

In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and ...